10-Q Filing

ENZON PHARMACEUTICALS, INC. CIK: 727510 Q2 2025

Filing Information

Form Type	10-Q
Accession Number	`0001410578-25-001810`
Period End Date	20250630
Filing Date	20250814
Fiscal Year	2025
Fiscal Period	Q2
XBRL Instance	enzn-20250630x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 102 Income Statement 124 Cash Flow Statement 60 Stockholders Equity 44

Balance Sheet 102 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$44.29M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$44.29M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$46.86M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$46.86M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$444.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$444.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$293.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$293.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$47.15M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$47.15M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$44.74M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$44.74M	USD	Point-in-time
Deferred tax asset	`DeferredIncomeTaxAssetsNet`	$42.00K	USD	Point-in-time
Deferred tax asset	`DeferredIncomeTaxAssetsNet`	$42.00K	USD	Point-in-time
Deferred tax asset	`DeferredIncomeTaxAssetsNet`	$17.00K	USD	Point-in-time
Deferred tax asset	`DeferredIncomeTaxAssetsNet`	$17.00K	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Total assets	`Assets`	$44.78M	USD	Point-in-time
Total assets	`Assets`	$44.78M	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Total assets	`Assets`	$47.17M	USD	Point-in-time
Total assets	`Assets`	$47.17M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	2.96M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	2.96M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	2.96M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	2.96M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$331.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$331.00K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$331.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$331.00K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$72.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$72.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$472.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$472.00K	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Dividends payable on Series C preferred stock	`DividendsPayableCurrent`	$1.27M	USD	Point-in-time
Dividends payable on Series C preferred stock	`DividendsPayableCurrent`	$1.27M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.68M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.68M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$803.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$803.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	74.21M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	74.21M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	74.21M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	74.21M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	74.21M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	74.21M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	74.21M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	74.21M	shares	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 2,960,000 shares; no shares issued and outstanding at June 30, 2025 and December 31, 2024	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 2,960,000 shares; no shares issued and outstanding at June 30, 2025 and December 31, 2024	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 2,960,000 shares; no shares issued and outstanding at June 30, 2025 and December 31, 2024	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 2,960,000 shares; no shares issued and outstanding at June 30, 2025 and December 31, 2024	`PreferredStockValue`	-	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 74,214,603 shares at June 30, 2025 and December 31, 2024	`CommonStockValue`	$742.00K	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 74,214,603 shares at June 30, 2025 and December 31, 2024	`CommonStockValue`	$742.00K	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 74,214,603 shares at June 30, 2025 and December 31, 2024	`CommonStockValue`	$742.00K	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 74,214,603 shares at June 30, 2025 and December 31, 2024	`CommonStockValue`	$742.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$72.16M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$72.16M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$71.10M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$71.10M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-69.89M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-69.89M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-71.41M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-71.41M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$432.00K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$432.00K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$3.04M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$3.04M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$3.01M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$3.01M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$1.95M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$1.95M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$3.50M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$3.50M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$3.29M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$3.29M	USD	Point-in-time
Total liabilities, mezzanine equity and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$44.78M	USD	Point-in-time
Total liabilities, mezzanine equity and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$44.78M	USD	Point-in-time
Total liabilities, mezzanine equity and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$47.17M	USD	Point-in-time
Total liabilities, mezzanine equity and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$47.17M	USD	Point-in-time

Income Statement 124 line items

Line Item	Tag	Value	Unit	Period
Royalties and milestones, net	`RoyaltyRevenueAndMilestones`	$26.00K	USD	1 Quarter
Royalties and milestones, net	`RoyaltyRevenueAndMilestones`	$26.00K	USD	1 Quarter
Royalties and milestones, net	`RoyaltyRevenueAndMilestones`	$26.00K	USD	2 Qtrs
Royalties and milestones, net	`RoyaltyRevenueAndMilestones`	$26.00K	USD	2 Qtrs
Total revenues	`Revenues`	$26.00K	USD	1 Quarter
Total revenues	`Revenues`	$26.00K	USD	1 Quarter
Total revenues	`Revenues`	$26.00K	USD	2 Qtrs
Total revenues	`Revenues`	$26.00K	USD	2 Qtrs
General and administrative	`OtherGeneralAndAdministrativeExpense`	$677.00K	USD	2 Qtrs
General and administrative	`OtherGeneralAndAdministrativeExpense`	$677.00K	USD	2 Qtrs
General and administrative	`OtherGeneralAndAdministrativeExpense`	$809.00K	USD	2 Qtrs
General and administrative	`OtherGeneralAndAdministrativeExpense`	$809.00K	USD	2 Qtrs
General and administrative	`OtherGeneralAndAdministrativeExpense`	$351.00K	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$351.00K	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$314.00K	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$314.00K	USD	1 Quarter
Transaction expenses	`TransactionExpenses`	$1.73M	USD	2 Qtrs
Transaction expenses	`TransactionExpenses`	$1.73M	USD	2 Qtrs
Transaction expenses	`TransactionExpenses`	$1.22M	USD	1 Quarter
Transaction expenses	`TransactionExpenses`	$1.22M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$677.00K	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$677.00K	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$351.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$351.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$2.54M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$2.54M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$1.53M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.53M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-2.54M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-2.54M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-325.00K	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-325.00K	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-1.53M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-1.53M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-651.00K	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-651.00K	USD	2 Qtrs
Interest and dividend income	`OtherInterestAndDividendIncome`	$501.00K	USD	1 Quarter
Interest and dividend income	`OtherInterestAndDividendIncome`	$501.00K	USD	1 Quarter
Interest and dividend income	`OtherInterestAndDividendIncome`	$1.25M	USD	2 Qtrs
Interest and dividend income	`OtherInterestAndDividendIncome`	$1.25M	USD	2 Qtrs
Interest and dividend income	`OtherInterestAndDividendIncome`	$605.00K	USD	1 Quarter
Interest and dividend income	`OtherInterestAndDividendIncome`	$605.00K	USD	1 Quarter
Interest and dividend income	`OtherInterestAndDividendIncome`	$998.00K	USD	2 Qtrs
Interest and dividend income	`OtherInterestAndDividendIncome`	$998.00K	USD	2 Qtrs
(Loss) income before income tax benefit (expense)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.03M	USD	1 Quarter
(Loss) income before income tax benefit (expense)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.03M	USD	1 Quarter
(Loss) income before income tax benefit (expense)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.54M	USD	2 Qtrs
(Loss) income before income tax benefit (expense)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.54M	USD	2 Qtrs
(Loss) income before income tax benefit (expense)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$280.00K	USD	1 Quarter
(Loss) income before income tax benefit (expense)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$280.00K	USD	1 Quarter
(Loss) income before income tax benefit (expense)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$601.00K	USD	2 Qtrs
(Loss) income before income tax benefit (expense)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$601.00K	USD	2 Qtrs
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$-42.00K	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$-42.00K	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$-23.00K	USD	2 Qtrs
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$-23.00K	USD	2 Qtrs
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$5.00K	USD	2 Qtrs
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$5.00K	USD	2 Qtrs
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$4.00K	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$4.00K	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-1.51M	USD	2 Qtrs
Net (loss) income	`NetIncomeLoss`	$-1.51M	USD	2 Qtrs
Net (loss) income	`NetIncomeLoss`	$276.00K	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$276.00K	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$320.00K	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$320.00K	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-524.00K	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-524.00K	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$596.00K	USD	2 Qtrs
Net (loss) income	`NetIncomeLoss`	$596.00K	USD	2 Qtrs
Net (loss) income	`NetIncomeLoss`	$-990.00K	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-990.00K	USD	1 Quarter
Accretion of dividend on Series C preferred stock	`PreferredStockDividendsIncomeStatementImpact`	$531.00K	USD	1 Quarter
Accretion of dividend on Series C preferred stock	`PreferredStockDividendsIncomeStatementImpact`	$531.00K	USD	1 Quarter
Accretion of dividend on Series C preferred stock	`PreferredStockDividendsIncomeStatementImpact`	$1.06M	USD	2 Qtrs
Accretion of dividend on Series C preferred stock	`PreferredStockDividendsIncomeStatementImpact`	$1.06M	USD	2 Qtrs
Accretion of dividend on Series C preferred stock	`PreferredStockDividendsIncomeStatementImpact`	$531.00K	USD	1 Quarter
Accretion of dividend on Series C preferred stock	`PreferredStockDividendsIncomeStatementImpact`	$531.00K	USD	1 Quarter
Accretion of dividend on Series C preferred stock	`PreferredStockDividendsIncomeStatementImpact`	$1.06M	USD	2 Qtrs
Accretion of dividend on Series C preferred stock	`PreferredStockDividendsIncomeStatementImpact`	$1.06M	USD	2 Qtrs
Net loss available to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.58M	USD	2 Qtrs
Net loss available to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.58M	USD	2 Qtrs
Net loss available to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.52M	USD	1 Quarter
Net loss available to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.52M	USD	1 Quarter
Net loss available to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-255.00K	USD	1 Quarter
Net loss available to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-255.00K	USD	1 Quarter
Net loss available to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-466.00K	USD	2 Qtrs
Net loss available to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-466.00K	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.01	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.01	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.02	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.02	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.03	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.03	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	-	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	-	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.02	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.02	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.01	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.01	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	-	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	-	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.03	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.03	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	-	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	-	USD	1 Quarter
Weighted average number of common shares - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	74.22M	shares	1 Quarter
Weighted average number of common shares - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	74.22M	shares	1 Quarter
Weighted average number of common shares - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	74.22M	shares	2 Qtrs
Weighted average number of common shares - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	74.22M	shares	2 Qtrs
Weighted average number of common shares - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	74.22M	shares	2 Qtrs
Weighted average number of common shares - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	74.22M	shares	2 Qtrs
Weighted average number of common shares - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	74.22M	shares	1 Quarter
Weighted average number of common shares - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	74.22M	shares	1 Quarter
Weighted average number of common shares - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	74.22M	shares	2 Qtrs
Weighted average number of common shares - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	74.22M	shares	2 Qtrs
Weighted average number of common shares - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	74.22M	shares	2 Qtrs
Weighted average number of common shares - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	74.22M	shares	2 Qtrs
Weighted average number of common shares - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	74.22M	shares	1 Quarter
Weighted average number of common shares - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	74.22M	shares	1 Quarter
Weighted average number of common shares - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	74.22M	shares	1 Quarter
Weighted average number of common shares - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	74.22M	shares	1 Quarter
Weighted average number of common shares - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	74.22M	shares	1 Quarter
Weighted average number of common shares - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	74.22M	shares	1 Quarter

Cash Flow Statement 60 line items

Line Item	Tag	Value	Unit	Period
Net Income (Loss)	`NetIncomeLoss`	$-1.51M	USD	2 Qtrs
Net Income (Loss)	`NetIncomeLoss`	$-1.51M	USD	2 Qtrs
Net Income (Loss)	`NetIncomeLoss`	$276.00K	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$276.00K	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$320.00K	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$320.00K	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$-524.00K	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$-524.00K	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$596.00K	USD	2 Qtrs
Net Income (Loss)	`NetIncomeLoss`	$596.00K	USD	2 Qtrs
Net Income (Loss)	`NetIncomeLoss`	$-990.00K	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$-990.00K	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$4.00K	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$4.00K	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$42.00K	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$42.00K	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-25.00K	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-25.00K	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$3.00K	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$3.00K	USD	2 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-249.00K	USD	2 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-249.00K	USD	2 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$107.00K	USD	2 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$107.00K	USD	2 Qtrs
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$492.00K	USD	2 Qtrs
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$492.00K	USD	2 Qtrs
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.29M	USD	2 Qtrs
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.29M	USD	2 Qtrs
Preferred stock dividend payments	`PaymentsOfDividendsCommonStock`	$1.27M	USD	2 Qtrs
Preferred stock dividend payments	`PaymentsOfDividendsCommonStock`	$1.27M	USD	2 Qtrs
Preferred stock dividend payments	`PaymentsOfDividendsCommonStock`	$1.27M	USD	2 Qtrs
Preferred stock dividend payments	`PaymentsOfDividendsCommonStock`	$1.27M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.27M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.27M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.27M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.27M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-2.56M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-2.56M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-783.00K	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-783.00K	USD	2 Qtrs
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$46.23M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$46.23M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$47.01M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$47.01M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$46.86M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$46.86M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$44.29M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$44.29M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$46.23M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$46.23M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$47.01M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$47.01M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$46.86M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$46.86M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$44.29M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$44.29M	USD	Point-in-time
Accretion of dividend for Series C Preferred Stock	`AccretionOfDividendForSeriesCPreferredStock`	$1.06M	USD	2 Qtrs
Accretion of dividend for Series C Preferred Stock	`AccretionOfDividendForSeriesCPreferredStock`	$1.06M	USD	2 Qtrs
Accretion of dividend for Series C Preferred Stock	`AccretionOfDividendForSeriesCPreferredStock`	$1.06M	USD	2 Qtrs
Accretion of dividend for Series C Preferred Stock	`AccretionOfDividendForSeriesCPreferredStock`	$1.06M	USD	2 Qtrs

Stockholders Equity 44 line items

Line Item	Tag	Value	Unit	Period
Balance at the beginning	`StockholdersEquity`	$432.00K	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$432.00K	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$3.04M	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$3.04M	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$3.01M	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$3.01M	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$1.95M	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$1.95M	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$3.50M	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$3.50M	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$3.29M	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$3.29M	USD	Point-in-time
Net Income (Loss)	`NetIncomeLoss`	$-1.51M	USD	2 Qtrs
Net Income (Loss)	`NetIncomeLoss`	$-1.51M	USD	2 Qtrs
Net Income (Loss)	`NetIncomeLoss`	$276.00K	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$276.00K	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$320.00K	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$320.00K	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$-524.00K	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$-524.00K	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$596.00K	USD	2 Qtrs
Net Income (Loss)	`NetIncomeLoss`	$596.00K	USD	2 Qtrs
Net Income (Loss)	`NetIncomeLoss`	$-990.00K	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$-990.00K	USD	1 Quarter
Preferred stock dividend accretion	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$531.00K	USD	1 Quarter
Preferred stock dividend accretion	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$531.00K	USD	1 Quarter
Preferred stock dividend accretion	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$531.00K	USD	1 Quarter
Preferred stock dividend accretion	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$531.00K	USD	1 Quarter
Preferred stock dividend accretion	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$531.00K	USD	1 Quarter
Preferred stock dividend accretion	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$531.00K	USD	1 Quarter
Preferred stock dividend accretion	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$531.00K	USD	1 Quarter
Preferred stock dividend accretion	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$531.00K	USD	1 Quarter
Balance at the ending	`StockholdersEquity`	$432.00K	USD	Point-in-time
Balance at the ending	`StockholdersEquity`	$432.00K	USD	Point-in-time
Balance at the ending	`StockholdersEquity`	$3.04M	USD	Point-in-time
Balance at the ending	`StockholdersEquity`	$3.04M	USD	Point-in-time
Balance at the ending	`StockholdersEquity`	$3.01M	USD	Point-in-time
Balance at the ending	`StockholdersEquity`	$3.01M	USD	Point-in-time
Balance at the ending	`StockholdersEquity`	$1.95M	USD	Point-in-time
Balance at the ending	`StockholdersEquity`	$1.95M	USD	Point-in-time
Balance at the ending	`StockholdersEquity`	$3.50M	USD	Point-in-time
Balance at the ending	`StockholdersEquity`	$3.50M	USD	Point-in-time
Balance at the ending	`StockholdersEquity`	$3.29M	USD	Point-in-time
Balance at the ending	`StockholdersEquity`	$3.29M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.